Qizhi Yishen capsules | China Drugs List

Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.

Medicine type: Traditional Chinese medicine
Therapeutic area: Kidney diseases
Indications recorded in the public source: In TCM, replenishes qi and nourishes yin, disperses blood stasis and unblocks the channels. For early diabetic nephropathy with deficiency of both qi and yin. Manifestations include fatigue and weakness, dry mouth and throat, heat in the palms, soles and chest, poor appetite, a dull complexion, numbness of the limbs, a pale or dark-red tongue or a tongue with ecchymoses, petechiae or scant coating, and a fine or fine-choppy pulse.
Indication source and scope: Source date(s): 2024, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
Prescribing-information limitations: Indications checked against an official public submission. The full original prescribing information is still unavailable.
China availability status: Historical Chinese approval verified; current continuous market availability has not been checked for every product.
Overseas status: Market-by-market verification pending.
Insurance classification: Included in national insurance (Category B)
Insurance edition: 2025 edition; effective 1 January 2026
Insurance restrictions: No additional restriction is specified for this NRDL entry; the general NRDL rules and legally approved indications still apply.
Insurance period: 2025-01-01 to 2026-12-31
Insurance verification notes: Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.

Sources

Open the interactive record, public price references and discussions